Ellefore desvenlafaxine regulatory update

Wyeth withdrew an MAA for Ellefore desvenlafaxine to treat major depressive disorder (MDD) after EMEA's CHMP raised concerns about the compound's efficacy. The company plans to begin a European Phase ...